Professor Manu Shankar-Hari will take up the position of Chair in Translational Critical Care Medicine at the University of Edinburgh’s Centre for Inflammation Research. He will be leaving Guy’s and St Thomas’ and King’s College London at the end of January 2022.

Manu joined the Trust as a consultant in intensive care medicine in 2009, and a clinical senior lecturer in intensive care medicine at King’s College London’s School of Immunology and Microbial Sciences. In 2016 he received an NIHR Clinician Scientist Award. His contributions to sepsis research were recognised with the ANZICS Intensive Care Global Rising Star Award in 2017 and International Sepsis Forum Lowry Fink Fellowship in 2019.

Manu’s research explores ways to improve outcomes in adult critically ill patients with sepsis and with ARDS by linking the illness immunobiology to interventional trial design.

As a clinician academic and R&D co-lead for critical care, Manu has contributed greatly to developing critical care research at the Trust with several important discoveries in the field of sepsis and ARDS immunology and treatment. During the pandemic, Manu led key COVID-19 trials whilst

working as a clinician and supporting the Trust’s critical care response to the pandemic.

He led on work that described the COVID-19 paediatric syndrome PIMS-TS. Work that he co-led prompted new WHO recommendations to use interleukin-6 antagonists for severe COVID-19 along with corticosteroids.

Professor Nick Hart, Director of Research Delivery and Clinical Director for Sleep, Respiratory and Critical Care said: “Manu has been an ardent advocate for clinical research throughout his time at the Trust, ensuring that patients remain at the heart of all that we do. On behalf of all colleagues across our NHS and academic partnership we wish Manu every success in the future.”

Professor Mike Malim, Head of the School of Immunology and Microbial Sciences at King’s College London added: “Manu’s contribution to immunology research at King’s has resulted in global patient benefit. He is a true scholar; it has been our privilege to host him within the School and witness his many accomplishments. We extend our warmest congratulations to Manu on this prestigious appointment, and look forward to continuing to collaborate with him in his new role.”